Literature DB >> 15561827

Penicillin-binding protein 2 is essential for expression of high-level vancomycin resistance and cell wall synthesis in vancomycin-resistant Staphylococcus aureus carrying the enterococcal vanA gene complex.

Anatoly Severin1, Shang Wei Wu, Keiko Tabei, Alexander Tomasz.   

Abstract

A combination of biochemical and genetic experiments were performed in order to better understand the mechanism of expression of high-level vancomycin resistance in Staphylococcus aureus. The transcription of pbp2 of the highly vancomycin- and oxacillin-resistant strain COLVA200 and its mutant derivative with inactivated mecA were put under the control of an inducible promoter, and the dependence of oxacillin and vancomycin resistance and cell wall composition on the concentration of the isopropyl-beta-D-thiogalactopyranoside inducer was determined. The results indicate that mecA--the genetic determinant of oxacillin resistance--while essential for oxacillin resistance, is not involved with the expression of vancomycin resistance. Penicillin binding protein 2A, the protein product of mecA, appears to be unable to utilize the depsipeptide cell wall precursor produced in the vancomycin-resistant cells for transpeptidation. The key penicillin binding protein essential for vancomycin resistance and for the synthesis of the abnormally structured cell walls characteristic of vancomycin-resistant S. aureus (A. Severin, K. Tabei, F. Tenover, M. Chung, N. Clarke, and A. Tomasz, J. Biol. Chem. 279:3398-3407, 2004) is penicillin binding protein 2.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15561827      PMCID: PMC529188          DOI: 10.1128/AAC.48.12.4566-4573.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

1.  Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene.

Authors:  Soju Chang; Dawn M Sievert; Jeffrey C Hageman; Matthew L Boulton; Fred C Tenover; Frances Pouch Downes; Sandip Shah; James T Rudrik; Guy R Pupp; William J Brown; Denise Cardo; Scott K Fridkin
Journal:  N Engl J Med       Date:  2003-04-03       Impact factor: 91.245

2.  Characterization of Staphylococcus aureus cell wall glycan strands, evidence for a new beta-N-acetylglucosaminidase activity.

Authors:  I G Boneca; Z H Huang; D A Gage; A Tomasz
Journal:  J Biol Chem       Date:  2000-04-07       Impact factor: 5.157

3.  Mechanism of bacitracin action: a specific lipid-peptide interaction.

Authors:  D R Storm
Journal:  Ann N Y Acad Sci       Date:  1974-05-10       Impact factor: 5.691

4.  Structural basis for the beta lactam resistance of PBP2a from methicillin-resistant Staphylococcus aureus.

Authors:  Daniel Lim; Natalie C J Strynadka
Journal:  Nat Struct Biol       Date:  2002-11

5.  Insertional inactivation of the mec gene in a transposon mutant of a methicillin-resistant clinical isolate of Staphylococcus aureus.

Authors:  P Matthews; A Tomasz
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

6.  An acquired and a native penicillin-binding protein cooperate in building the cell wall of drug-resistant staphylococci.

Authors:  M G Pinho; H de Lencastre; A Tomasz
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

7.  Complementation of the essential peptidoglycan transpeptidase function of penicillin-binding protein 2 (PBP2) by the drug resistance protein PBP2A in Staphylococcus aureus.

Authors:  M G Pinho; S R Filipe; H de Lencastre; A Tomasz
Journal:  J Bacteriol       Date:  2001-11       Impact factor: 3.490

8.  Mechanism of action of bacitracin: complexation with metal ion and C 55 -isoprenyl pyrophosphate.

Authors:  K J Stone; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1971-12       Impact factor: 11.205

9.  High level oxacillin and vancomycin resistance and altered cell wall composition in Staphylococcus aureus carrying the staphylococcal mecA and the enterococcal vanA gene complex.

Authors:  Anatoly Severin; Keiko Tabei; Fred Tenover; Marilyn Chung; Nancy Clarke; Alexander Tomasz
Journal:  J Biol Chem       Date:  2003-11-12       Impact factor: 5.157

10.  Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus.

Authors:  Linda M Weigel; Don B Clewell; Steven R Gill; Nancye C Clark; Linda K McDougal; Susan E Flannagan; James F Kolonay; Jyoti Shetty; George E Killgore; Fred C Tenover
Journal:  Science       Date:  2003-11-28       Impact factor: 47.728

View more
  17 in total

1.  In vitro pharmacodynamics of vancomycin and cefazolin alone and in combination against methicillin-resistant Staphylococcus aureus.

Authors:  Mao Hagihara; Dora E Wiskirchen; Joseph L Kuti; David P Nicolau
Journal:  Antimicrob Agents Chemother       Date:  2011-10-17       Impact factor: 5.191

2.  Successful therapy of experimental endocarditis caused by vancomycin-resistant Staphylococcus aureus with a combination of vancomycin and beta-lactam antibiotics.

Authors:  Paige M Fox; Russell J Lampen; Katrina S Stumpf; Gordon L Archer; Michael W Climo
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

3.  VraSR two-component regulatory system and its role in induction of pbp2 and vraSR expression by cell wall antimicrobials in Staphylococcus aureus.

Authors:  Shaohui Yin; Robert S Daum; Susan Boyle-Vavra
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

4.  Structural variations of the cell wall precursor lipid II and their influence on binding and activity of the lipoglycopeptide antibiotic oritavancin.

Authors:  Daniela Münch; Ina Engels; Anna Müller; Katrin Reder-Christ; Hildegard Falkenstein-Paul; Gabriele Bierbaum; Fabian Grein; Gerd Bendas; Hans-Georg Sahl; Tanja Schneider
Journal:  Antimicrob Agents Chemother       Date:  2014-11-17       Impact factor: 5.191

5.  VraR Binding to the Promoter Region of agr Inhibits Its Function in Vancomycin-Intermediate Staphylococcus aureus (VISA) and Heterogeneous VISA.

Authors:  Yuanyuan Dai; Wenjiao Chang; Changcheng Zhao; Jing Peng; Liangfei Xu; Huaiwei Lu; Shusheng Zhou; Xiaoling Ma
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

6.  Daptomycin-oxacillin combinations in treatment of experimental endocarditis caused by daptomycin-nonsusceptible strains of methicillin-resistant Staphylococcus aureus with evolving oxacillin susceptibility (the "seesaw effect").

Authors:  Soo-Jin Yang; Yan Q Xiong; Susan Boyle-Vavra; Robert Daum; Tiffanny Jones; Arnold S Bayer
Journal:  Antimicrob Agents Chemother       Date:  2010-06-14       Impact factor: 5.191

Review 7.  Mechanisms of vancomycin resistance in Staphylococcus aureus.

Authors:  Susana Gardete; Alexander Tomasz
Journal:  J Clin Invest       Date:  2014-07-01       Impact factor: 14.808

8.  Synergism between beta-lactams and glycopeptides against VanA-type methicillin-resistant Staphylococcus aureus and heterologous expression of the vanA operon.

Authors:  Bruno Périchon; Patrice Courvalin
Journal:  Antimicrob Agents Chemother       Date:  2006-09-05       Impact factor: 5.191

Review 9.  A current perspective on daptomycin for the clinical microbiologist.

Authors:  Romney M Humphries; Simon Pollett; George Sakoulas
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

10.  Spontaneous deletion of the methicillin resistance determinant, mecA, partially compensates for the fitness cost associated with high-level vancomycin resistance in Staphylococcus aureus.

Authors:  Michael J Noto; Paige M Fox; Gordon L Archer
Journal:  Antimicrob Agents Chemother       Date:  2008-01-22       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.